Xilio Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for XLO, updated each market day.
XLO AI Sentiment
AI predicts Xilio Therapeutics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Xilio Therapeutics, Inc. Common Stock
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
Sector
Exchange
Market Cap
$49,498,294
Cap Tier
Employees
76
Headquarters
WALTHAM, MA
Listed Since
Oct. 22, 2021
Website
XLO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
XLO Volatility
Xilio Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
